Unresectable Locally Advanced Pancreatic Cancer: Treatment With Neoadjuvant Leucovorin, Fluorouracil, Irinotecan, and Oxaliplatin and Assessment of Surgical Resectability

被引：9
作者：
Mondo, Esther Liu [1 ]
Noel, Marcus S. [2 ]
Katz, Alan W. [2 ]
Schoeniger, Luke O. [2 ]
Hezel, Aram F. [2 ]
机构：
[1] Univ Rochester, Med Ctr, Sch Med & Dent, Rochester, NY 14627 USA
[2] Univ Rochester, Med Ctr, Sch Med & Dent, James P Wilmot Canc Ctr, Rochester, NY 14642 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 03期
关键词：
CHEMOTHERAPY; GEMCITABINE;
D O I：
10.1200/JCO.2012.44.0339
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：E37 / E39
页数：3
相关论文
共 50 条
[31]   Role of neoadjuvant concurrent chemoradiation in locally advanced unresectable pancreatic cancer: A feasibility study at tertiary care centre [J].
Kapoor, R. ;
Khosla, D. ;
Gupta, R. ;
Bahl, A. ;
Shukla, A. K. ;
Sharma, S. C. .
INDIAN JOURNAL OF CANCER, 2014, 51 (02) :176-179
[32]   FOLFOX regimen after failure of fluorouracil and leucovorin plus nanoliposomal-irinotecan therapy for advanced pancreatic cancer: a retrospective observational study [J].
Kobayashi, Satoshi ;
Tezuka, Shun ;
Yamachika, Yui ;
Tsunoda, Shotaro ;
Nagashima, Shuhei ;
Tozuka, Yuichiro ;
Fukushima, Taito ;
Morimoto, Manabu ;
Ueno, Makoto ;
Furuse, Junji ;
Maeda, Shin .
BMC CANCER, 2023, 23 (01)
[33]   Efficacy and Safety of the Combination of Nano-Liposomal Irinotecan and 5-Fluorouracil/L-Leucovorin in Unresectable Advanced Pancreatic Cancer: A Real-World Study [J].
Yasuoka, Hidetoshi ;
Naganuma, Atsushi ;
Kurihara, Eishin ;
Kobatake, Tsutomu ;
Ijima, Masashi ;
Tamura, Yuki ;
Suzuki, Yuhei ;
Hoshino, Takashi ;
Ishida, Fumiya ;
Hosaka, Hisashi ;
Hatanaka, Takeshi ;
Yoshida, Sachiko ;
Aihara, Ryusuke ;
Hosouchi, Yasuo ;
Ishii, Norihiro ;
Araki, Kenichiro ;
Shirabe, Ken ;
Uraoka, Toshio ;
Kakizaki, Satoru .
ONCOLOGY, 2022, 100 (08) :449-459
[34]   Liposomal irinotecan plus fluorouracil/leucovorin in older patients with advanced pancreatic cancer: a single-center retrospective study [J].
Nagashima, Shuhei ;
Kobayashi, Satoshi ;
Tsunoda, Shotaro ;
Yamachika, Yui ;
Tozuka, Yuichiro ;
Fukushima, Taito ;
Morimoto, Manabu ;
Ueno, Makoto ;
Furuse, Junji ;
Maeda, Shin .
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2024, 29 (02) :188-194
[35]   Biomarker analysis for patients with pancreatic cancer treated with nanoliposomal irinotecan plus 5-fluorouracil/leucovorin [J].
Kawakami, Takeshi ;
Todaka, Akiko ;
Oshima, Kotoe ;
Fushiki, Kunihiro ;
Hamauchi, Satoshi ;
Tsushima, Takahiro ;
Yokota, Tomoya ;
Onozawa, Yusuke ;
Yasui, Hirofumi ;
Yamazaki, Kentaro .
BMC CANCER, 2023, 23 (01)
[36]   The use of irinotecan and oxaliplatin in the treatment of advanced colorectal cancer [J].
Poston, GJ .
EJSO, 2005, 31 (04) :325-330
[37]   Detecting tumour response and predicting resectability after neoadjuvant therapy for borderline resectable and locally advanced pancreatic cancer [J].
Barreto, Savio G. ;
Loveday, Benjamin ;
Windsor, John A. ;
Pandanaboyana, Sanjay .
ANZ JOURNAL OF SURGERY, 2019, 89 (05) :481-487
[38]   Clinical outcome of neoadjuvant chemoradiation therapy with oxaliplatin and capecitabine or 5-fluorouracil for locally advanced rectal cancer [J].
Lu, Jun-Yang ;
Xiao, Yi ;
Qiu, Hui-Zhong ;
Wu, Bin ;
Lin, Guo-Le ;
Xu, Lai ;
Zhang, Guan-Nan ;
Hu, Ke .
JOURNAL OF SURGICAL ONCOLOGY, 2013, 108 (04) :213-219
[39]   Complete Pathological Remission of Locally Advanced, Unresectable Pancreatic Cancer (LAPC) after Intensified Neoadjuvant Chemotherapy [J].
Hartlapp, Ingo ;
Mueller, Justus ;
Kenn, Werner ;
Steger, Ulrich ;
Isbert, Christoph ;
Scheurlen, Michael ;
Germer, Christoph-Thomas ;
Einsele, Hermann ;
Kunzmann, Volker .
ONKOLOGIE, 2013, 36 (03) :123-125
[40]   How to approach pancreatic cancer after neoadjuvant treatment: assessment of resectability using multidetector CT and tumor markers [J].
Jeon, Sun Kyung ;
Lee, Jeong Min ;
Lee, Eun Sun ;
Yu, Mi Hye ;
Joo, Ijin ;
Yoon, Jeong Hee ;
Jang, Jin-Young ;
Lee, Kyoung Bun ;
Lee, Sang Hyup .
EUROPEAN RADIOLOGY, 2022, 32 (01) :56-66
12345